Gene · 6046
Papers3,414
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 3,414
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Age differences in endocannabinoid tone are ameliorated after recent cannabis use. | Sci Rep | 2026 | 41580496 | PubTator, text mining | PubMed |
| The Disordered Region of ASXL1 Acts as an Auto-Regulator Through Condensation. | Adv Sci (Weinh) | 2026 | 41556087 | PubTator, text mining | PubMed |
| Highly effective combination of BRG1/BRM inhibitor with BET inhibitor or decitabine for high-risk MECOM-rearranged AML. | Hemasphere | 2026 | 41551728 | PubTator, text mining | PubMed |
| Integrative analysis of single-cell and bulk RNA sequencing data for discovery of senescent TAMs prognostic characteristics in neuroblastoma. | BMC Cancer | 2026 | 41491450 | PubTator, text mining | PubMed |
| BRD2 bridges TFIID and MOF-H4K16ac-containing nucleosomes to promote transcriptional initiation. | Mol Cell | 2026 | 41478281 | PubTator, text mining | PubMed |
| Development of cell-active BRD4-D1 selective inhibitors to decode the role of BET proteins in LPS-mediated liver inflammation. | Eur J Med Chem | 2026 | 41448046 | PubTator, text mining | PubMed |
| Interphase chromosome conformation is specified by distinct folding programmes inherited through mitotic chromosomes or the cytoplasm. | Nat Cell Biol | 2026 | 41429936 | PubTator, text mining | PubMed |
| The HYAL1 paradox in cancer: From complex tumor biology to novel therapeutic strategies. | Transl Oncol | 2026 | 41421148 | PubTator, text mining | PubMed |
| Computer assisted discovery of novel nicotinamide phosphoribosyltransferase agonists to combat muscle atrophy. | Bioorg Chem | 2026 | 41317575 | PubTator, text mining | PubMed |
| Dysregulation of the BRD2-FGF17 Signal Pathway Induces Abnormal Forebrain Development Associated with Schizophrenia. | Neurosci Bull | 2026 | 40947439 | PubTator, text mining | PubMed |
| 3D genome folding in epigenetic regulation and cellular memory. | Trends Cell Biol | 2026 | 40221344 | PubTator, text mining | PubMed |
| An induced pluripotent stem cell-based chemical genetic approach for studying spinal muscular atrophy. | Front Neurosci | 2025 | 41716912 | PubTator, text mining | PubMed |
| The role of super-enhancer-driven lncRNAs in cancer. | Comput Struct Biotechnol J | 2025 | 41542082 | PubTator, text mining | PubMed |
| Identification of novel therapeutic targets for diabetic neuropathy through integrated proteomics and transcriptomics approaches. | World J Diabetes | 2025 | 41480606 | PubTator, text mining | PubMed |
| Advancing PROTAC Discovery Through Artificial Intelligence: Opportunities, Challenges, and Future Directions. | Pharmaceuticals (Basel) | 2025 | 41471282 | PubTator, text mining | PubMed |
| Deep learning-guided discovery of selective JAK2-JH2 allosteric inhibitors: integration of MLP predictive modeling, BREED-based library design, and computational validation. | Front Chem | 2025 | 41404389 | PubTator, text mining | PubMed |
| Challenges and opportunities for oncology drug repurposing informed by synthetic lethality. | NPJ Syst Biol Appl | 2025 | 41390513 | PubTator, text mining | PubMed |
| BRD2 impedes iPSC reprogramming by regulating lipogenesis and matrisome. | Res Sq | 2025 | 41377977 | PubTator, text mining | PubMed |
| Multi-Omics Mendelian Randomization Identifies Therapeutic Targets for Sjögren's Disease with Clinical and Bayesian Validation. | J Inflamm Res | 2025 | 41333034 | PubTator, text mining | PubMed |
| Histone demethylase KDM9 activates the CCND1/AKT pathway to promote the malignant progression of gliomas through interaction with BRD2. | Cell Mol Life Sci | 2025 | 41291235 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6046/papers?page=3